Anti-GPIb/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients
This retrospective study aimed to evaluate whether anti-glycoproteins (GPs) autoantibodies can be used as predictors of response to high-dose dexamethasone combined with rituximab (DXM-RTX) in the treatment of primary immune thrombocytopenia (ITP) patients. One-hundred twenty-six ITP patients were i...
Main Authors: | Bingjie Ding, Liu Liu, Mengjuan Li, Xuewen Song, Yuanyuan Zhang, Ao Xia, Jingyuan Liu, Hu Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2023.2258988 |
Similar Items
-
GPIb-IX-V and platelet clearance
by: M. Edward Quach
Published: (2022-08-01) -
Soy Isoflavones Inhibit Both GPIb-IX Signaling and αIIbβ3 Outside-In Signaling via 14-3-3ζ in Platelet
by: Ming Liu, et al.
Published: (2021-08-01) -
GPIbα is the driving force of hepatic thrombopoietin generation
by: Danielle Karakas, et al.
Published: (2021-05-01) -
The Efficacy of High-Dose Dexamethasone vs. Other Treatments for Newly Diagnosed Immune Thrombocytopenia: A Meta-Analysis
by: Qirong Xiao, et al.
Published: (2021-05-01) -
The spirit of place dynamics at GPIB Immanuel and the Pancaran Kasih in Depok
by: Riajeng Sinta Damayanti, et al.
Published: (2022-04-01)